Feb 8 (Reuters) - Ambu A/S AMBUb.CO :
* REG-AMBU A/S: INTERIM REPORT FOR Q1 2021/22
* REG-AMBU A/S: INTERIM REPORT FOR Q1 2021/22
* Q1 REVENUE DKK 1,031 MILLION VERSUS DKK 1,013 MILLION YEAR
AGO
* Q1 EBIT EX. ITEMS DKK 40 MILLION VERSUS DKK 148 MILLION
YEAR AGO
* OUTLOOK FOR 2021/22 FINANCIAL YEAR IS REVISED DUE TO
UNCERTAINTIES REGARDING CONTINUED IMPACT OF OMICRON
* OUTLOOK FY 2021/22: OUTLOOK FOR ORGANIC GROWTH IS REVISED
FROM
"15-19%" TO "15%+" (15 PERCENT OR HIGHER)
* OUTLOOK FY 2021/22: EBIT MARGIN IS REVISED FROM "7-9%" TO
"7%+"
(7 PERCENT OR HIGHER)
* OUTLOOK FY 2021/22: ORGANIC GROWTH OF 15%+
* OUTLOOK FY 2021/22:
* Q1 SALES OF ENDOSCOPES AT 419,000 UNITS VERSUS 370,000
UNITS
YEAR AGO
Source text for Eikon: ID:nGNE4KbbSv
Further company coverage: AMBUb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))